Literature DB >> 29032060

Emerging Therapeutics for the Control of Chronic Graft-versus-Host Disease.

Kelli P A MacDonald1, Brian C Betts2, Daniel Couriel3.   

Abstract

Keywords:  Allogeneic hematopoietic cell transplantation; Chronic GVHD; Graft-versus-host disease; Interleukin-17A; JAK inhibitor

Mesh：

Substances：

Year:  2017        PMID： 29032060     DOI： 10.1016/j.bbmt.2017.10.006

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  9 in total

Review 1.  Oral Complications of Chronic Graft-Versus-Host Disease.

Authors:  Jane M Fall-Dickson; Steven Z Pavletic; Jacqueline W Mays; Mark M Schubert
Journal:  J Natl Cancer Inst Monogr       Date:  2019-08-01

Review 2.  Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review.

Authors:  Han Jie Soh; Courtney Samuel; Victoria Heaton; William Douglas Renton; Angela Cox; Jane Munro
Journal:  Rheumatol Int       Date:  2019-03-05       Impact factor: 2.631

Review 3.  How I treat refractory chronic graft-versus-host disease.

Authors:  Stefanie Sarantopoulos; Adela R Cardones; Keith M Sullivan
Journal:  Blood       Date:  2019-01-23       Impact factor: 22.113

Review 4.  B cells in chronic graft-versus-host disease.

Authors:  William McManigle; Ayman Youssef; Stefanie Sarantopoulos
Journal:  Hum Immunol       Date:  2019-03-05       Impact factor: 2.850

5.  Current Concepts and Advances in Graft-Versus-Host Disease Immunology.

Authors:  Geoffrey R Hill; Brian C Betts; Victor Tkachev; Leslie S Kean; Bruce R Blazar
Journal:  Annu Rev Immunol       Date:  2021-01-11       Impact factor: 28.527

6.  Patient-reported outcomes and health status associated with chronic graft-versus-host disease.

Authors:  Stephanie J Lee; Lynn Onstad; Eric J Chow; Bronwen E Shaw; Heather S L Jim; Karen L Syrjala; K Scott Baker; Sarah Buckley; Mary E Flowers
Journal:  Haematologica       Date:  2018-06-01       Impact factor: 9.941

Review 7.  Functional Contributions of Antigen Presenting Cells in Chronic Graft-Versus-Host Disease.

Authors:  Chao Hong; Rong Jin; Xiaoqiu Dai; Xiaoming Gao
Journal:  Front Immunol       Date:  2021-02-24       Impact factor: 7.561

8.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report.

Authors:  Zachariah DeFilipp; Daniel R Couriel; Aleksandr Lazaryan; Vijaya Raj Bhatt; Nataliya P Buxbaum; Amin M Alousi; Attilio Olivieri; Drazen Pulanic; Joerg P Halter; Lori A Henderson; Robert Zeiser; Ted A Gooley; Kelli P A MacDonald; Daniel Wolff; Kirk R Schultz; Sophie Paczesny; Yoshihiro Inamoto; Corey S Cutler; Carrie L Kitko; Joseph A Pidala; Stephanie J Lee; Gerard Socie; Stefanie Sarantopoulos; Steven Z Pavletic; Paul J Martin; Bruce R Blazar; Hildegard T Greinix
Journal:  Transplant Cell Ther       Date:  2021-06-11

9.  Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium.

Authors:  Zachariah DeFilipp; Amin M Alousi; Joseph A Pidala; Paul A Carpenter; Lynn E Onstad; Sally Arai; Mukta Arora; Corey S Cutler; Mary E D Flowers; Carrie L Kitko; George L Chen; Stephanie J Lee; Betty K Hamilton
Journal:  Blood Adv       Date:  2021-10-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.